[Management of neurogenic bladder patients in France: a survey carried out by the French-speaking neurourology study group (GENULF)].
OBJECTIVE
To design and run a survey aiming at investigating urologists' and physiatrists' clinical practices in France when managing neurogenic bladder patients.


METHODS
Three thousand one hundred and eighty questionnaires were sent to the members of four French societies involved in treating neurogenic bladder dysfunction. Questions were focused on consultations, clinical follow-up and patient management.


RESULTS
Two hundred and seventy-four urologists and 109 physiatrists completed the questionnaire. The frequency of systematic follow-up differed between urologists (6 months) and physiatrists (12 months). Upper urinary tract imaging and systematic urodynamic follow-up were usually performed yearly. The latter was carried out by 56% urologists and 83% physiatrists. Urinary retention was essentially treated by intermittent catheterization. Less than 15% of urologists and physiatrists were treating bacteriuria. Symptomatic urinary infections were treated for 11 to 12 days (men) and for 8 to 9 days (women). To treat their patients, both specialists used self-catheterization education and botulinum toxin A injections.


CONCLUSIONS
Our survey showed differences in approach between urologists and physiatrists in the management of patients with neurogenic bladder dysfunction. Their clinical practice was most of the time in line with national and international guidelines.
Service de médecine physique et de réadaptation, hôpital Raymond-Poincaré, 92380 Garches, France. pierre.denys@rpc.ap-hop-paris.fr
P
P
Denys
J-M
JM
Soler
B
B
Fatton
P
P
Rischmann
A
A
Yelnik
P
P
Aegerter
N-Y
NY
Saidji-Domingo
E
E
Chartier-Kastler
D005260:Female; D005602:France; D006801:Humans; D008297:Male; D010810:Physical and Rehabilitation Medicine; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires; D001750:Urinary Bladder, Neurogenic / Q000628:therapy*; D016055:Urinary Retention / Q000628:therapy; D014572:Urology